Retrospective Crossover of Patients with Primary Immunodeficiency Switching from Standard Immune Globulin Replacement Therapy to ASCENIV
Artículo
Acceso abierto
Artículo
DOAJ
ASCENIV is a 10% intravenous immune globulin (IVIG) indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age). ASCENIV contains a blend of normal source plasma...
LCC LCC:Immunologic diseases. AllergyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access